Role of Endogenous Cannabinoids in Synaptic Signaling

Physiological Reviews - Tập 83 Số 3 - Trang 1017-1066 - 2003
Tamás F. Freund1,2,3, István Katona1,2,3, Daniele Piomelli1,2,3
1Department of Clinical Neurobiology, University Hospital of Neurology, Heidelberg, Germany
2Department of Pharmacology, University of California Irvine, Irvine, California
3Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary; Department of Clinical Neurobiology, University Hospital of Neurology, Heidelberg, Germany; and Department of Pharmacology, University of California Irvine, Irvine, California

Tóm tắt

Freund, Tamás F., István Katona, and Daniele Piomelli. Role of Endogenous Cannabinoids in Synaptic Signaling. Physiol Rev 83: 1017–1066, 2003; 10.1152/physrev.00004.2003.—Research of cannabinoid actions was boosted in the 1990s by remarkable discoveries including identification of endogenous compounds with cannabimimetic activity (endocannabinoids) and the cloning of their molecular targets, the CB1and CB2receptors. Although the existence of an endogenous cannabinoid signaling system has been established for a decade, its physiological roles have just begun to unfold. In addition, the behavioral effects of exogenous cannabinoids such as delta-9-tetrahydrocannabinol, the major active compound of hashish and marijuana, await explanation at the cellular and network levels. Recent physiological, pharmacological, and high-resolution anatomical studies provided evidence that the major physiological effect of cannabinoids is the regulation of neurotransmitter release via activation of presynaptic CB1receptors located on distinct types of axon terminals throughout the brain. Subsequent discoveries shed light on the functional consequences of this localization by demonstrating the involvement of endocannabinoids in retrograde signaling at GABAergic and glutamatergic synapses. In this review, we aim to synthesize recent progress in our understanding of the physiological roles of endocannabinoids in the brain. First, the synthetic pathways of endocannabinoids are discussed, along with the putative mechanisms of their release, uptake, and degradation. The fine-grain anatomical distribution of the neuronal cannabinoid receptor CB1is described in most brain areas, emphasizing its general presynaptic localization and role in controlling neurotransmitter release. Finally, the possible functions of endocannabinoids as retrograde synaptic signal molecules are discussed in relation to synaptic plasticity and network activity patterns.

Từ khóa


Tài liệu tham khảo

10.1021/jm00038a020

10.1016/S1388-1981(99)00137-7

10.1016/S0014-2999(00)00403-9

10.1016/S0014-2999(01)00967-0

10.1002/(SICI)1096-9861(19970217)378:3<320::AID-CNE2>3.0.CO;2-5

AdamsAR. Marihuana.Harvey Lect37: 168–168, 1941.

10.1016/S0306-4522(01)00601-7

10.1016/S0306-4522(00)00389-4

10.1016/S0167-4838(00)00137-0

10.1016/0166-2236(95)93923-L

10.1113/jphysiol.1996.sp021677

10.1038/sj.bjp.0703642

10.1016/S0028-3908(01)00145-9

10.1126/science.1465619

10.1038/sj.bjp.0702478

10.1016/S0304-3940(97)00673-3

10.1152/jn.2000.83.6.3287

10.1152/physrev.1992.72.3.699

10.1016/0896-6273(93)90086-7

10.1152/jn.1998.79.2.659

10.1016/S0304-3940(01)01591-9

10.1523/JNEUROSCI.20-09-03401.2000

10.1016/S0014-5793(97)00061-6

10.1097/00001756-200004270-00018

10.1126/science.277.5329.1094

10.1046/j.1432-1327.2001.02072.x

10.1042/bj3510817

BodorA, KatonaI, MackieK,andFreundTF. Cellular and subcellular localization of CB1 cannabinoid receptor in rat somatosensory cortex.FENS Abstr1: 284, 2002.

10.1016/S0960-894X(00)00528-X

10.1073/pnas.97.10.5044

BohmeGA, LavilleM, LedentC, ParmentierM,andImperatoA. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors.Neuroscience95: 5–7, 2000.

10.1074/jbc.270.23.13973

10.1042/bj3120637

10.1126/science.1076535

10.1097/00001756-200006260-00044

10.1124/mol.60.1.155

10.1074/jbc.273.27.16865

BreivogelCS, SimLJ,andChildersSR. Regional differences in cannabinoid receptor/G-protein coupling in rat brain.J Pharmacol Exp Ther282: 1632–1642, 1997.

10.1016/0006-2952(85)90504-0

10.1016/0006-8993(92)90110-U

BuckleyNE, HanssonS, HartaG,andMezeyE. Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat.Neuroscience82: 1131–1149, 1998.

10.1016/0028-3908(82)90071-5

10.1016/0006-8993(86)91483-6

10.1523/JNEUROSCI.17-04-01226.1997

10.1523/JNEUROSCI.16-12-03934.1996

10.1038/35040576

10.1016/S0014-2999(97)01184-9

10.1038/28393

10.1016/S0014-2999(01)00988-8

CampbellKA, FosterTC, HampsonRE,andDeadwylerSA. delta 9-Tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat dentate gyrus.J Pharmacol Exp Ther239: 936–940, 1986.

CampbellKA, FosterTC, HampsonRE,andDeadwylerSA. Effects of delta 9-tetrahydrocannabinol on sensory-evoked discharges of granule cells in the dentate gyrus of behaving rats.J Pharmacol Exp Ther239: 941–945, 1986.

10.1523/JNEUROSCI.15-02-01249.1995

10.1038/nn879

10.1016/S0006-8993(98)00738-0

10.1038/39807

10.1111/j.1476-5381.1992.tb14321.x

10.1007/s004410100461

10.1097/00001756-199803090-00020

10.1016/S0304-3940(98)00396-6

10.1093/emboj/20.24.7033

10.1038/378075a0

10.1016/0014-2999(94)90666-1

10.1111/j.1476-5381.1995.tb15889.x

ComptonDRandMartinBR. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity.J Pharmacol Exp Ther283: 1138–1143, 1997.

ComptonDR, RiceKC, DeCostaBR, RazdanRK, MelvinLS, JohnsonMR,andMartinBR. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.J Pharmacol Exp Ther265: 218–226, 1993.

10.1016/0091-3057(75)90144-6

10.1124/mol.58.6.1188

10.1073/pnas.161191698

10.1038/384083a0

10.1126/science.7770779

10.1021/jm00079a016

10.1002/neu.480250612

10.1124/mol.59.6.1369

DeadwylerSA, HampsonRE, BennettBA, EdwardsTA, MuJ, PachecoMA, WardSJ,andChildersSR. Cannabinoids modulate potassium current in cultured hippocampal neurons.Receptors Channels1: 121–134, 1993.

DeadwylerSA, HampsonRE, MuJ, WhyteA,andChildersS. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process.J Pharmacol Exp Ther273: 734–743, 1995.

10.1111/j.1360-0443.1991.tb01776.x

10.1016/S0014-2999(02)01996-9

10.1016/S0896-6273(02)00641-4

10.1016/S0014-5793(00)02082-2

10.1074/jbc.270.11.6030

10.1016/0006-2952(93)90486-G

10.1006/bbrc.1997.6072

10.1073/pnas.91.14.6698

DevaneWA, DysarzFA, JohnsonMR III, MelvinLS,andHowlettAC. Determination and characterization of a cannabinoid receptor in rat brain.Mol Pharmacol34: 605–613, 1988.

10.1126/science.1470919

10.1523/JNEUROSCI.21-21-08328.2001

10.1523/JNEUROSCI.22-01-00200.2002

DiMarzoV, BreivogelCS, TaoQ, BridgenDT, RazdanRK, ZimmerAM, ZimmerA,andMartinBR. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.J Neurochem75: 2434–2444, 2000.

10.1038/372686a0

10.1038/35071088

10.1016/S0014-2999(01)01012-3

10.1016/S0166-2236(98)01283-1

10.1073/pnas.152334899

10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1

10.1098/rspb.1998.0543

10.1016/S0896-6273(00)80683-2

10.1111/j.1471-4159.1992.tb09787.x

EvansDM, LakeJT, JohnsonMR,andHowlettAC. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.J Pharmacol Exp Ther268: 1271–1277, 1994.

10.1073/pnas.92.8.3376

10.1111/j.1749-6632.1989.tb22596.x

10.1016/0020-711X(86)90244-2

10.1006/mcne.2000.0844

10.1073/pnas.86.23.9584

10.1002/jnr.1224

10.1016/S0014-5793(02)02341-4

10.1038/25541

10.1152/physrev.1998.78.1.143

10.1054/plef.2001.0357

10.1006/abbi.1998.1025

FowlerCJ, TigerG,andStenstromA. Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship.J Pharmacol Exp Ther283: 729–734, 1997.

10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I

10.1016/0014-2999(93)90468-W

10.1111/j.1432-1033.1995.tb20780.x

10.1021/ja01062a046

10.1006/nbdi.1998.0219

10.1152/jn.2001.85.1.468

10.1038/nn832

10.1016/S0014-2999(98)00486-5

10.1073/pnas.94.6.2238

GiffordANandAshbyCR Jr. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212–2, and is potentiated by the cannabinoid antagonist, SR 141716A.J Pharmacol Exp Ther277: 1431–1436, 1996.

10.1038/sj.bjp.0703599

10.1016/S0014-2999(97)00082-4

10.1016/S0304-3940(97)00851-3

GiuffridaA, BeltramoM,andPiomelliD. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology.J Pharmacol Exp Ther298: 7–14, 2001.

10.1038/7268

10.1016/S0009-3084(00)00193-6

10.1016/S0014-2999(00)00786-X

10.1097/00001756-199501000-00004

10.1016/S0306-4522(96)00428-9

10.1113/jphysiol.1996.sp021786

GobelI, TrendelenburgAU, CoxSL, MeyerA,andStarkeK. Electrically evoked release of [(3)H]norepinephrine from mouse cultured sympathetic neurons: release-modulating heteroreceptors.J Neurochem75: 2087–2094, 2000.

10.1016/S0024-3205(99)00251-9

10.1016/S0006-2952(98)00314-1

10.1016/S0014-5793(97)01603-7

10.1038/258424a0

10.1385/MN:24:1-3:029

10.1016/S0028-3908(02)00157-0

10.1046/j.1460-9568.2000.00217.x

10.1016/S0306-4522(01)00287-1

10.1016/S0306-4522(97)00300-X

10.1046/j.1471-4159.1998.70020671.x

10.1006/nbdi.1998.0223

10.1073/pnas.061029898

10.1021/jm00072a026

10.1016/S0896-6273(01)00447-0

10.1016/S0006-3495(96)79653-4

10.1038/14788

10.1016/0304-3940(95)11289-9

10.1016/0006-8993(91)90096-E

10.1016/0006-8993(91)90970-7

10.1523/JNEUROSCI.11-02-00563.1991

10.1073/pnas.87.5.1932

10.1007/BF03179772

10.1016/S0304-3940(96)13308-5

HeyserCJ, HampsonRE,andDeadwylerSA. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells.J Pharmacol Exp Ther264: 294–307, 1993.

10.1046/j.1471-4159.1997.69020631.x

HillardCJ, HarrisRA,andBloomAS. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.J Pharmacol Exp Ther232: 579–588, 1985.

HillardCJ, MannaS, GreenbergMJ, DiCamelliR, RossRA, StevensonLA, MurphyV, PertweeRG,andCampbellWB. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).J Pharmacol Exp Ther289: 1427–1433, 1999.

10.1016/0005-2760(95)00087-S

10.1073/pnas.95.15.8625

10.1523/JNEUROSCI.20-07-02470.2000

10.1152/jn.2001.85.1.72

10.1016/S0006-8993(98)01321-3

10.1002/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K

10.1016/S0306-4522(98)00524-7

10.1124/pr.54.2.161

10.1016/0166-2236(90)90124-S

10.1124/mol.61.3.578

10.1111/j.1469-7793.2001.0731e.x

10.1038/364723a0

10.1016/S0306-4522(00)00120-2

10.1111/j.1476-5381.1996.tb15639.x

10.1016/S1471-4892(01)00120-5

10.1016/S0304-3959(98)00041-4

10.1073/pnas.96.24.14136

JarrahianA, MannaS, EdgemondWS, CampbellWB,andHillardCJ. Structure-activity relationships amongN-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter.J Neurochem74: 2597–2606, 2000.

10.1111/j.1469-7793.2001.00805.x

10.1016/S0092-8674(05)80025-X

10.1016/S0959-4388(99)80042-7

10.1074/jbc.272.43.27218

10.1016/S1388-1981(99)00124-9

10.1007/s002109900091

10.1007/s002100000304

10.1038/sj.bjp.0703987

10.1038/nm803

10.1523/JNEUROSCI.21-23-09506.2001

10.1016/S0306-4522(00)00286-4

10.1523/JNEUROSCI.19-11-04544.1999

10.1152/jn.1997.77.6.3013

10.1093/cercor/7.6.476

10.1016/S0006-8993(00)03021-3

10.1016/0006-8993(95)00521-Q

10.1016/S0306-4522(00)00127-5

10.1155/2001/326867

10.1016/S0006-8993(97)01212-2

10.1016/S0896-6273(00)80971-X

10.1038/8138

KoutekB, PrestwichGD, HowlettAC, ChinSA, SalehaniD, AkhavanN,andDeutschDG. Inhibitors of arachidonoyl ethanolamide hydrolysis.J Biol Chem269: 22937–22940, 1994.

10.1523/JNEUROSCI.21-20-j0005.2001

10.1016/S0896-6273(01)00246-X

KruszkaKKandGrossRW. The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor.J Biol Chem269: 14345–14348, 1994.

10.1139/y83-063

10.1006/bbrc.1997.7180

10.1021/jm980461j

10.1126/science.3704635

10.1002/syn.10054

LawrenceDKandGillEW. The effects of delta1-tetrahydrocannabinol and other cannabinoids on spin-labeled liposomes and their relationship to mechanisms of general anesthesia.Mol Pharmacol11: 595–602, 1975.

10.1126/science.283.5400.401

10.1111/j.1469-7793.1999.00147.x

10.1111/j.1469-7793.1998.061bf.x

10.1111/j.1469-7793.1998.867bj.x

10.1124/jpet.302.1.73

LittlePJ, ComptonDR, JohnsonMR, MelvinLS,andMartinBR. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.J Pharmacol Exp Ther247: 1046–1051, 1988.

10.1016/0896-6273(91)90059-9

10.1021/jm015545y

10.1023/A:1007052507911

10.1111/j.1460-9568.1996.tb01611.x

10.1016/S0891-0618(97)00051-3

10.1016/S0304-3940(01)02471-5

10.1016/0306-4522(89)90180-2

10.1073/pnas.89.9.3825

10.1523/JNEUROSCI.15-10-06552.1995

10.1016/S0896-6273(01)00375-0

10.1126/science.275.5297.209

10.1016/0306-4522(92)90409-U

10.1016/0304-3940(92)90832-R

10.1093/emboj/20.1.47

10.1523/JNEUROSCI.22-09-03326.2002

10.1523/JNEUROSCI.21-20-08238.2001

10.1016/S0014-2999(01)00723-3

10.1046/j.1460-9568.1999.00847.x

10.1016/S0306-4522(98)00745-3

10.1111/j.1469-7793.2001.0685e.x

10.1523/JNEUROSCI.16-20-06601.1996

10.1002/cne.903270406

10.1038/346561a0

10.1016/0361-9230(87)90087-6

10.1016/0014-2999(96)00015-5

McAllisterSD, GriffinG, SatinLS,andAboodME. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in aXenopusoocyte expression system.J Pharmacol Exp Ther291: 618–626, 1999.

10.1016/S0306-4522(01)00380-3

MechoulamR.The Pharmacohistory of Cannabis sativa.Boca Raton, FL: CRC, 1986.

10.1016/0006-2952(95)00109-D

10.1016/0006-2952(94)90197-X

10.1016/S0306-4522(00)00496-6

10.1038/26481

10.1016/S0896-6273(00)80101-4

10.1016/0014-2999(95)00151-A

10.1016/0014-2999(96)00111-2

10.1016/S0014-2999(98)00374-4

10.1037/0033-2909.93.3.441

10.1523/JNEUROSCI.19-16-06795.1999

10.1016/S0196-9781(00)00324-7

10.1006/bbrc.2002.6635

10.1002/hipo.10025

10.1523/JNEUROSCI.17-09-03157.1997

10.1002/1098-1063(2000)10:3<261::AID-HIPO6>3.0.CO;2-1

10.1523/JNEUROSCI.18-13-04870.1998

10.1016/S0014-2999(01)01309-7

10.1152/jn.2001.86.1.40

10.1038/365061a0

10.1006/nbdi.1998.0224

10.1016/S0896-6273(00)81125-3

10.1523/JNEUROSCI.20-22-08365.2000

10.1007/s002109900147

10.1111/j.1471-4159.1984.tb12750.x

10.1111/j.1471-4159.1983.tb00825.x

10.1016/0005-2760(86)90341-3

10.1016/S0028-3908(01)00075-2

10.1016/0361-9230(87)90052-9

10.1046/j.1460-9568.2001.01407.x

10.1016/S0896-6273(01)00247-1

10.1046/j.1460-9568.2002.01929.x

10.1523/JNEUROSCI.22-10-03864.2002

10.1016/0301-0082(79)90005-4

10.1002/hipo.450030307

10.1016/S0306-4522(99)00025-1

10.1016/S0306-4522(00)00584-4

10.1016/S0028-3908(98)00096-3

10.1021/bi991876p

10.1016/S0959-4388(00)00076-3

10.1016/S0301-0082(00)00031-9

PetersenG, ChapmanKD,andHansenHS. A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: application ton-acylethanolamine formation in vitro.J Lipid Res41: 1532–1538, 2000.

10.1016/S0014-5793(99)00861-3

10.1002/(SICI)1097-4547(19980201)51:3<391::AID-JNR12>3.0.CO;2-A

PiomelliD.Arachidonic Acid in Cell Signaling. Heidelberg, Germany: Springer-Verlag, 1996.

10.1073/pnas.96.10.5802

10.1016/S0165-6147(00)01482-6

10.1523/JNEUROSCI.12-10-04122.1992

10.1016/0896-6273(94)90430-8

10.1046/j.1460-9568.1998.00175.x

10.1124/jpet.301.3.1020

10.1523/JNEUROSCI.22-09-03454.2002

RakhshanF, DayTA, BlakelyRD,andBarkerEL. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.J Pharmacol Exp Ther292: 960–967, 2000.

10.1016/0014-4886(73)90290-2

10.1016/S0009-3084(00)00185-7

10.1016/S0014-2999(97)01621-X

10.1016/S0304-3959(97)00213-3

10.1016/0014-5793(94)00773-X

10.1016/0024-3205(96)00085-9

10.1523/JNEUROSCI.21-01-00109.2001

10.1073/pnas.122149199

10.1523/JNEUROSCI.21-03-00823.2001

10.1038/35102582

10.1016/S0306-4522(97)00552-6

10.1385/JMN:11:2:109

10.1016/S0376-8716(98)00036-2

10.1016/S0169-328X(02)00167-5

10.1016/S0024-3205(98)00594-3

SagratellaS, Scotti deCarolisA,andLongoVG. EEG interaction between delta 8-tetrahydrocannabinol and some sedative-anxiolytic drugs. Is the anxiogenic effect of Cannabis related to an action on the GABAergic system?Adv Biochem Psychopharmacol41: 203–209, 1986.

10.1016/S0306-4522(01)00584-X

10.1097/00001756-200112040-00017

10.1016/S0024-3205(99)00293-3

10.1152/jn.1997.77.3.1635

10.1016/S0024-3205(97)00804-7

10.1016/0092-8674(94)90252-6

10.1007/PL00005093

10.1016/0163-7827(90)90004-5

10.1073/pnas.94.8.4188

10.1523/JNEUROSCI.20-01-00051.2000

10.1016/0014-2999(74)90200-3

10.1016/0024-3205(96)00347-5

10.1523/JNEUROSCI.16-14-04322.1996

10.1073/pnas.082235799

10.1016/S0165-6147(00)01459-0

10.1523/JNEUROSCI.05-08-02169.1985

10.1016/S0014-2999(01)01182-7

10.1038/42015

10.1523/JNEUROSCI.22-07-02460.2002

10.1006/bbrc.1995.2437

10.1111/j.1432-1033.1996.0053h.x

10.1006/bbrc.1996.0020

10.1152/jn.1999.82.3.1286

10.1016/S0306-4522(97)00597-6

10.1016/S0306-4522(00)00036-1

SzallasiAandBlumbergPM. Vanilloid (Capsaicin) receptors and mechanisms.Pharmacol Rev51: 159–212, 1999.

10.1152/jn.2000.83.3.1167

10.1007/BF00169393

10.1016/0006-8993(96)00533-1

10.1002/(SICI)1097-4547(19971215)50:6<1047::AID-JNR16>3.0.CO;2-1

ThompsonGA.The Regulation of Membrane Lipid Metabolism(2nd ed.). Boca Raton, FL: CRC, 1992.

10.1523/JNEUROSCI.21-04-01104.2001

10.1113/jphysiol.1997.sp022033

10.1038/sj.bjp.0703305

10.1016/S0306-4522(97)00436-3

10.1016/S0306-4522(99)00086-X

10.1016/S0304-3940(98)00700-9

10.1002/j.1552-4604.1981.tb01748.x

10.1152/jn.1997.78.1.43

10.1074/jbc.270.40.23823

10.1016/0005-2760(94)00170-4

10.1016/S0014-5793(99)00820-0

10.1074/jbc.M106261200

10.1046/j.0953-816x.2001.01652.x

10.1053/gast.2001.28466

10.1016/0361-9230(77)90036-3

10.1523/JNEUROSCI.21-24-j0003.2001

VaughanCW, ConnorM, BagleyEE,andChristieMJ. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.Mol Pharmacol57: 288–295, 2000.

10.1038/sj.bjp.0702636

10.1016/0896-6273(93)90118-B

10.1113/jphysiol.1996.sp021484

ViziES. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system.Pharmacol Rev52: 63–89, 2000.

10.1016/S0014-2999(01)01413-3

10.1113/jphysiol.1996.sp021577

10.1073/pnas.96.21.12198

10.1155/2001/413641

10.1007/s00210-001-0520-z

10.1152/jn.00723.2001

10.1016/0361-9230(82)90042-9

10.1016/0306-4522(94)90511-8

10.1038/301603a0

10.1016/0361-9230(87)90166-3

10.1038/341739a0

10.1016/S0896-6273(01)00372-5

10.1038/35069076

10.1002/hipo.450050110

10.1523/JNEUROSCI.22-05-01690.2002

10.1111/j.1469-7793.2000.00489.x

10.1016/S0896-6273(00)81044-2

10.1073/pnas.96.10.5780

10.1038/22761

Thông tin
Thông tin xuất bản

Physiological Reviews

Tập 83 Số 3

1017-1066

Thông tin tác giả